Default: Applied Health Economics and Health Policy

ISSN: 1175-5652

Journal Home

Journal Guideline

Applied Health Economics and Health Policy Q1 Unclaimed

Springer International Publishing AG Switzerland
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Applied Health Economics and Health Policy is a journal indexed in SJR in Medicine (miscellaneous) and Economics and Econometrics with an H index of 56. It has a price of 3190 €. It has an SJR impact factor of 1,291 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,291.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Price

3190 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Applied Health Economics and Health Policy

1,291

SJR Impact factor

56

H Index

80

Total Docs (Last Year)

225

Total Docs (3 years)

4063

Total Refs

812

Total Cites (3 years)

208

Citable Docs (3 years)

3.55

Cites/Doc (2 years)

50.79

Ref/Doc

Comments

No comments ... Be the first to comment!



Best articles by citations

Key Performance Indicators for the Implementation of Social Health Insurance

View more

Untangling the Debate Surrounding Strategies for Achieving Sustainable High Coverage of Insecticide-Treated Nets

View more

Affordability of Medicines and Patients??? Cost-Reducing Behaviour

View more

Self-Reported Effectiveness of Double-Fine Zones as a Speed Control Measure

View more

Recycling Blood

View more

Opportunities for Use of Blockchain Technology in Medicine

View more

Using Economic Analyses for Local Priority Setting

View more

A Macroeconomic Approach to Evaluating Policies to Contain Antimicrobial Resistance

View more

Do Interventions to Increase Income Improve the Health of the Poor in Developed Economies and Are Such Policies Cost Effective?

View more

Modelling the Costs and Outcomes of Changing Rates of Screening for Alcohol Misuse by GPs in the Australian Context

View more

The Economics of Prevention in a Post-Managed-Care Environment

View more

Medicare Coverage and Reimbursement of Outpatient Prescription Drugs in the US

View more
SHOW MORE ARTICLES

Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement

View more

Senior Citizens and the Burden of Prescription Drug Outlays

View more

The Impact of CT Colonography for Colorectal Cancer Screening on the UK NHS

View more

Genetic Health Technology and Economic Evaluation

View more

Disease-Specific Impoverishment Impact of Out-of-Pocket Payments for Health Care: Evidence from Rural Bangladesh

View more

To Retain or Remove User Fees?

View more

Comparing Utility Scores Before and After Hearing-Aid Provision

View more

EQ-5D versus SF-6D in an Older, Chronically Ill Patient Group

View more

Medicare Payment Policy and the Controversy over Hospital Cost Shifting

View more

Economic Analysis of Thrombo inCode, a Clinical-Genetic Function for Assessing the Risk of Venous Thromboembolism

View more

Community-based interventions to promote increased physical activity

View more

Opioid Misuse Among Adolescents: New Evidence from a Misclassification Analysis

View more

FAQS